The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Vokes, Everett E.
One or more keywords matched the following items that are connected to Vokes, Everett E.
Item TypeName
Concept Academic Medical Centers
Concept Activities of Daily Living
Concept Aged, 80 and over
Concept Arachidonate 5-Lipoxygenase
Concept Adolescent
Concept Aged
Concept Analgesics, Opioid
Concept Blood Pressure
Concept Amino Acid Sequence
Concept Administration, Oral
Concept Adult
Concept Antibodies, Monoclonal
Concept Arsenicals
Concept Base Sequence
Concept Benzamides
Concept Benzimidazoles
Concept Biological Availability
Concept Carmustine
Concept Dental Alloys
Concept DNA Damage
Concept Azacitidine
Concept Bilirubin
Concept Biopsy, Needle
Concept Cancer Care Facilities
Concept Carbon Monoxide
Concept Child
Concept Cell Transformation, Neoplastic
Concept Bronchoscopy
Concept Cisplatin
Concept Leucovorin
Concept Demography
Concept DNA-Binding Proteins
Concept Cysteine Endopeptidases
Concept Drug Synergism
Concept Immunosuppressive Agents
Concept Interleukin-2
Concept Cytochrome P-450 Enzyme System
Concept DNA Repair
Concept Cause of Death
Concept DNA Mutational Analysis
Concept Glucocorticoids
Concept Enteral Nutrition
Concept Erythrocyte Count
Concept Immunologic Factors
Concept Erythropoietin
Concept Etoposide
Concept Developing Countries
Concept DNA
Concept Drug Interactions
Concept Indoles
Concept Fluorouracil
Concept Esophagitis
Concept Fibroblast Growth Factors
Concept Neoplasms, Hormone-Dependent
Concept Killer Cells, Natural
Concept Health Facilities
Concept Oncogenes
Concept Osteoradionecrosis
Concept DNA Topoisomerases, Type I
Concept DNA, Viral
Concept Dose-Response Relationship, Drug
Concept Dyspnea
Concept Laryngeal Neoplasms
Concept Liver Neoplasms
Concept Herpesvirus 4, Human
Concept Flow Cytometry
Concept Infant
Concept International Cooperation
Concept Leukocytes, Mononuclear
Concept Macrophages
Concept Carcinoma, Hepatocellular
Concept Hospitals, University
Concept Hospitals, Veterans
Concept Mice, Inbred Strains
Concept Pharmacogenetics
Concept Pilot Projects
Concept Lymphopenia
Concept Platelet-Derived Growth Factor
Concept Pneumonia, Aspiration
Concept Immunohistochemistry
Concept Indazoles
Concept Oral Health
Concept Organoplatinum Compounds
Concept Oropharyngeal Neoplasms
Concept Molecular Sequence Data
Concept Neoplastic Cells, Circulating
Concept Pain
Concept Pancreatic Neoplasms
Concept Mesothelioma
Concept Methotrexate
Concept Mice, Nude
Concept Middle Aged
Concept Radiotherapy, Computer-Assisted
Concept Mouthwashes
Concept Phosphorylcholine
Concept Ovarian Neoplasms
Concept Liver
Concept Safety
Concept Oligopeptides
Concept Speech Intelligibility
Concept Phosphorylation
Concept Physician's Role
Concept Morpholines
Concept Mouth
Concept Mouth Mucosa
Concept Probability
Concept Preoperative Care
Concept Prostatic Neoplasms
Concept Pleural Neoplasms
Concept Protein-Tyrosine Kinases
Concept Proto-Oncogene Proteins
Concept Forecasting
Concept Glutamates
Concept Immunoglobulin G
Concept Immunoenzyme Techniques
Concept Regression Analysis
Concept Guanine
Concept Radiation-Sensitizing Agents
Concept Postoperative Period
Concept Risk Factors
Concept Quinolines
Concept Radiotherapy Planning, Computer-Assisted
Concept Interferon-gamma
Concept ROC Curve
Concept Interleukin-6
Concept Risk
Concept Tachycardia, Supraventricular
Concept Societies, Medical
Concept Humans
Concept Body Mass Index
Concept Tomography, X-Ray Computed
Concept Tretinoin
Concept Thalidomide
Concept Thionucleotides
Concept Tumor Necrosis Factor-alpha
Concept Caenorhabditis elegans
Concept Hepatocyte Growth Factor
Concept Practice Guidelines as Topic
Concept Radiation Pneumonitis
Concept Universities
Concept Multicenter Studies as Topic
Concept Leukemia, Lymphocytic, Chronic, B-Cell
Concept Isotretinoin
Concept Lymphoma, Follicular
Concept Mastication
Concept Carcinoma, Neuroendocrine
Concept Oncogene Proteins, Fusion
Concept Proportional Hazards Models
Concept Macrophage Colony-Stimulating Factor
Concept Risk Assessment
Concept Drug Resistance, Neoplasm
Concept Observation
Concept Mitogen-Activated Protein Kinases
Concept Carboplatin
Concept Transforming Growth Factor beta
Concept Central Nervous System Neoplasms
Concept Up-Regulation
Concept Quinolones
Concept Neoplasms, Second Primary
Concept Activin Receptors, Type I
Concept Radiosurgery
Concept Lymph Nodes
Concept Lymphatic Metastasis
Concept CD4-Positive T-Lymphocytes
Concept Comorbidity
Concept Mutagenesis, Site-Directed
Concept In Situ Hybridization
Concept Prostate-Specific Antigen
Concept Protein Structure, Tertiary
Concept Receptors, Endothelin
Concept Medical Oncology
Concept Melanoma
Concept Paraffin Embedding
Concept Treatment Outcome
Concept Neoplasm Metastasis
Concept Neoplasm Recurrence, Local
Concept Interferon-alpha
Concept Mice, Knockout
Concept CD8-Positive T-Lymphocytes
Concept Disease Progression
Concept Muscle, Skeletal
Concept ras Proteins
Concept src-Family Kinases
Concept Angiogenesis Inhibitors
Concept Health Transition
Concept Cyclooxygenase 2 Inhibitors
Concept Gene Regulatory Networks
Concept Receptor Protein-Tyrosine Kinases
Concept Mutation, Missense
Concept Immunoconjugates
Concept In Situ Hybridization, Fluorescence
Concept Organ Preservation
Concept Organs at Risk
Concept Clinical Trials Data Monitoring Committees
Concept Vascular Endothelial Growth Factor Receptor-2
Concept Population Groups
Concept Positron-Emission Tomography
Concept Radiotherapy, Intensity-Modulated
Concept Proteomics
Concept Paired Box Transcription Factors
Concept Human papillomavirus 18
Concept Proteasome Endopeptidase Complex
Concept Mitogen-Activated Protein Kinase 3
Concept Proto-Oncogene Proteins c-bcl-2
Concept Area Under Curve
Concept Cyclin-Dependent Kinase Inhibitor p16
Concept Proto-Oncogene Proteins c-kit
Concept Oligonucleotide Array Sequence Analysis
Concept Evidence-Based Medicine
Concept Papillomaviridae
Concept Radiotherapy, Conformal
Concept Lymphoma, Mantle-Cell
Concept STAT3 Transcription Factor
Concept Periodicals as Topic
Concept Pharynx
Concept Phthalazines
Concept Platinum
Concept Polyethylene Glycols
Concept Placebos
Concept Postoperative Care
Concept Mice
Concept Protein Kinase C
Concept Quinazolines
Concept National Cancer Institute (U.S.)
Concept DNA Breaks, Double-Stranded
Concept Research Design
Concept Receptor, EphB4
Concept Sulfonamides
Concept Technology, Radiologic
Concept Uncertainty
Concept Biomedical Research
Concept Receptors, Vascular Endothelial Growth Factor
Concept Proto-Oncogene Proteins c-cbl
Concept Paxillin
Concept PAX5 Transcription Factor
Concept TOR Serine-Threonine Kinases
Concept Real-Time Polymerase Chain Reaction
Concept Antibodies, Monoclonal, Humanized
Concept Sex Factors
Concept Video Recording
Concept Adaptor Proteins, Signal Transducing
Concept Suramin
Concept Mesna
Concept Immunoblotting
Concept Blotting, Western
Concept Small Cell Lung Carcinoma
Concept Rad51 Recombinase
Concept Cyclooxygenase 2
Concept Logistic Models
Concept Transforming Growth Factor alpha
Concept DNA Copy Number Variations
Concept Cyclosporine
Concept Vinblastine
Concept Organ Sparing Treatments
Concept Survival Rate
Concept Odds Ratio
Concept Polymerase Chain Reaction
Concept Granulocyte Colony-Stimulating Factor
Concept Proto-Oncogene Proteins p21(ras)
Concept Patient Selection
Concept Receptor, ErbB-2
Concept Lymphoma, Large B-Cell, Diffuse
Concept DNA Methylation
Concept Receptors, CCR2
Concept Proto-Oncogene Proteins c-met
Concept Xenograft Model Antitumor Assays
Concept SEER Program
Concept Gadolinium DTPA
Concept O(6)-Methylguanine-DNA Methyltransferase
Concept Inhibitory Concentration 50
Concept Receptor, EphA2
Concept Extracellular Signal-Regulated MAP Kinases
Concept Keratin-19
Concept Genome-Wide Association Study
Concept Precision Medicine
Concept RNA, Small Interfering
Concept Molecular Sequence Annotation
Concept Ribosomal Protein S6 Kinases, 70-kDa
Concept Vascular Endothelial Growth Factor A
Concept Depsipeptides
Concept Intracellular Signaling Peptides and Proteins
Concept Cytochrome P-450 CYP3A
Concept Human papillomavirus 16
Concept Kaplan-Meier Estimate
Concept Benzenesulfonates
Concept Brain Neoplasms
Concept Deoxycytidine
Concept Drug Eruptions
Concept Epidermal Growth Factor
Concept Hypopharyngeal Neoplasms
Concept Lymphoma, Non-Hodgkin
Concept Mucins
Concept Nasopharyngeal Neoplasms
Concept Neoplasm Invasiveness
Concept Niacinamide
Concept Orthodontic Appliances
Concept Oxides
Concept Peptides
Concept Phenotype
Concept Pneumonectomy
Concept Predictive Value of Tests
Concept Prospective Studies
Concept Speech
Concept Sulindac
Concept Otorhinolaryngologic Surgical Procedures
Concept T-Lymphocytes
Concept Tumor Suppressor Protein p53
Concept Cytokines
Concept Oligonucleotides, Antisense
Concept Anticarcinogenic Agents
Concept Age of Onset
Concept DNA Primers
Concept Macrolides
Concept Computational Biology
Concept Cyclin D1
Concept Genetic Predisposition to Disease
Concept Maximum Tolerated Dose
Concept Genomics
Concept Semaphorins
Concept p38 Mitogen-Activated Protein Kinases
Concept Proto-Oncogene Proteins c-akt
Concept Alphapapillomavirus
Concept Young Adult
Concept Research Report
Academic Article Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.
Academic Article A phase II trial of 9-aminocaptothecin (9-AC) as a 120-h infusion in patients with non-small cell lung cancer.
Academic Article A phase I study of suramin with once- or twice-monthly dosing in patients with advanced cancer.
Academic Article Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study.
Academic Article Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.
Academic Article Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck.
Academic Article Intensive concurrent chemoradiotherapy for head and neck cancer with 5-Fluorouracil- and hydroxyurea-based regimens: reversing a pattern of failure.
Academic Article Phase II study of the farnesyl transferase inhibitor R115777 in patients with advanced non-small-cell lung cancer.
Academic Article The importance of quality-of-life measurements in oncology.
Academic Article Swallowing dysfunction--preventative and rehabilitation strategies in patients with head-and-neck cancers treated with surgery, radiotherapy, and chemotherapy: a critical review.
Academic Article Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy.
Academic Article Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
Academic Article Phase II trial of PS-341 in patients with renal cell cancer: a University of Chicago phase II consortium study.
Academic Article Is patient travel distance associated with survival on phase II clinical trials in oncology?
Academic Article Prioritizing treatment outcomes: head and neck cancer patients versus nonpatients.
Academic Article Dose-ranging study of the safety and pharmacokinetics of atrasentan in patients with refractory malignancies.
Academic Article Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy.
Academic Article Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan.
Academic Article Phase I study of G3139, a bcl-2 antisense oligonucleotide, combined with carboplatin and etoposide in patients with small-cell lung cancer.
Academic Article Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck.
Academic Article Modulation of irinotecan with cyclosporine: a phase II trial in advanced colorectal cancer.
Academic Article Phase II trials of dolastatin-10 in advanced pancreaticobiliary cancers.
Academic Article Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.
Academic Article Phase I/II trial of gefitinib and oxaliplatin in patients with advanced colorectal cancer.
Academic Article A Phase II study of oxaliplatin in urothelial cancer.
Academic Article Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.
Academic Article A randomized phase II trial of the matrix metalloproteinase inhibitor BMS-275291 in hormone-refractory prostate cancer patients with bone metastases.
Academic Article A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer.
Academic Article Therapeutic options for laryngeal cancer.
Academic Article Phase II trial of the O6-alkylguanine DNA alkyltransferase inhibitor O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea in advanced melanoma.
Academic Article Phase I study of induction chemotherapy and concomitant chemoradiotherapy with irinotecan, carboplatin, and paclitaxel for stage III non-small cell lung cancer.
Academic Article Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
Academic Article Irinogenetics: what is the right star?
Academic Article Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer.
Academic Article Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer.
Academic Article 9-Aminocamptothecin (9-AC) given as a 120-hour continuous infusion in patients with advanced adenocarcinomas of the stomach and gastroesophageal junction: A phase II trial of the University of Chicago phase II consortium.
Academic Article Pharmacogenomic and pharmacokinetic determinants of erlotinib toxicity.
Academic Article Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia.
Academic Article Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16INK4a: results of cancer and leukemia group B 159904.
Academic Article A Phase II trial of suramin monthly x 3 for hormone-refractory prostate carcinoma.
Academic Article Phase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B Trial 9430.
Academic Article PAX5 is expressed in small-cell lung cancer and positively regulates c-Met transcription.
Academic Article MET as a target for treatment of chest tumors.
Academic Article Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer.
Academic Article Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment.
Academic Article Protein kinase C beta in malignant pleural mesothelioma.
Academic Article Update in head and neck oncology.
Academic Article Aspiration in chemoradiated patients with head and neck cancer.
Academic Article The expanding role of systemic therapy in head and neck cancer.
Academic Article The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.
Academic Article Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer.
Academic Article Concurrent chemoradiotherapy for head and neck cancer.
Academic Article An initial report of a radiation dose-escalation trial in patients with one to five sites of metastatic disease.
Academic Article Expression and mutational analysis of MET in human solid cancers.
Academic Article Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.
Academic Article Chemoradiation for patients with advanced oral cavity cancer.
Academic Article EphA2 mutation in lung squamous cell carcinoma promotes increased cell survival, cell invasion, focal adhesions, and mammalian target of rapamycin activation.
Academic Article Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR.
Academic Article Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers.
Academic Article High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial.
Academic Article Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study.
Academic Article Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.
Academic Article Ethnic differences and functional analysis of MET mutations in lung cancer.
Academic Article A phase II study of sorafenib in advanced uterine carcinoma/carcinosarcoma: a trial of the Chicago, PMH, and California Phase II Consortia.
Academic Article Neck dissection planning based on postchemoradiation computed tomography in patients with head and neck cancer.
Academic Article Carboplatin and Paclitaxel in combination with either vorinostat or placebo for first-line therapy of advanced non-small-cell lung cancer.
Academic Article CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases.
Academic Article Chemoreirradiation for recurrent salivary gland malignancies.
Academic Article Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer.
Academic Article Gemcitabine plus sorafenib in patients with advanced pancreatic cancer: a phase II trial of the University of Chicago Phase II Consortium.
Academic Article A phase II study of ixabepilone (BMS-247550) in metastatic renal-cell carcinoma.
Academic Article Factors associated with long-term speech and swallowing outcomes after chemoradiotherapy for locoregionally advanced head and neck cancer.
Academic Article Response of human prostate cancer cells and tumors to combining PARP inhibition with ionizing radiation.
Academic Article Proteomic characterization of non-small cell lung cancer in a comprehensive translational thoracic oncology database.
Academic Article Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation.
Academic Article Head and neck cancer in 2010: Maximizing survival and minimizing toxicity.
Academic Article Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
Academic Article A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers.
Academic Article Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck.
Academic Article Phase II study of sunitinib malate in head and neck squamous cell carcinoma.
Academic Article Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103.
Academic Article Cediranib in patients with malignant mesothelioma: a phase II trial of the University of Chicago Phase II Consortium.
Academic Article Chemoradiation for patients with large-volume laryngeal cancers.
Academic Article Concurrent chemotherapy and intensity-modulated radiotherapy for organ preservation of locoregionally advanced oral cavity cancer.
Academic Article Bortezomib for patients with advanced-stage bronchioloalveolar carcinoma: a California Cancer Consortium Phase II study (NCI 7003).
Academic Article Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy.
Academic Article Predictors of competing mortality in advanced head and neck cancer.
Academic Article A phase II study of sorafenib in malignant mesothelioma: results of Cancer and Leukemia Group B 30307.
Academic Article Planned post-chemoradiation neck dissection: significance of radiation dose.
Academic Article Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies.
Academic Article Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy.
Academic Article MET and phosphorylated MET as potential biomarkers in lung cancer.
Academic Article Vatalanib in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (CALGB 30107).
Academic Article Efficacy of the multi-kinase inhibitor enzastaurin is dependent on cellular signaling context.
Academic Article Role of protein kinase C ß and vascular endothelial growth factor receptor in malignant pleural mesothelioma: Therapeutic implications and the usefulness of Caenorhabditis elegans model organism.
Academic Article Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease.
Academic Article Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small cell lung cancer.
Academic Article Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion.
Academic Article Factors associated with clinical benefit from epidermal growth factor receptor inhibitors in recurrent and metastatic squamous cell carcinoma of the head and neck.
Academic Article The epothilone B analogue ixabepilone in patients with advanced hepatobiliary cancers: a trial of the University of Chicago Phase II Consortium.
Academic Article Neck response to chemoradiotherapy: complete radiographic response correlates with pathologic complete response in locoregionally advanced head and neck cancer.
Academic Article Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction.
Academic Article Radiotherapy: Accelerated radiotherapy for HNSCC in developing countries.
Academic Article Personalized treatment of lung cancer.
Academic Article Phase II study of dasatinib in patients with previously treated malignant mesothelioma (cancer and leukemia group B 30601): a brief report.
Academic Article Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck.
Academic Article Site of disease and treatment protocol as correlates of swallowing function in patients with head and neck cancer treated with chemoradiation.
Academic Article Effects of radiotherapy with or without chemotherapy on tongue strength and swallowing in patients with oral cancer.
Academic Article Key signaling pathways and targets in lung cancer therapy.
Academic Article Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.
Academic Article Arsenic trioxide in patients with adenocarcinoma of the pancreas refractory to gemcitabine: a phase II trial of the University of Chicago Phase II Consortium.
Academic Article The role of EGFR inhibition in the treatment of non-small cell lung cancer.
Academic Article Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer.
Academic Article Germline polymorphisms discovered via a cell-based, genome-wide approach predict platinum response in head and neck cancers.
Academic Article RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.
Academic Article Everolimus exhibits efficacy as a radiosensitizer in a model of non-small cell lung cancer.
Academic Article Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma.
Academic Article Utilisation of a thoracic oncology database to capture radiological and pathological images for evaluation of response to chemotherapy in patients with malignant pleural mesothelioma.
Academic Article Searching for a standard.
Academic Article Randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy followed by concomitant chemoradiotherapy for stage IIIB non-small-cell lung cancer: cancer and leukemia group B study 9431.
Academic Article Induction chemotherapy and radiotherapy in locally advanced non-small cell lung cancer.
Academic Article Induction paclitaxel/carboplatin followed by concurrent chemoradiation therapy for unresectable stage III non-small-cell lung cancer: a limited-access study--CALGB 9534.
Academic Article The chemoradiation paradigm in head and neck cancer.
Academic Article The concurrent chemoradiation paradigm--general principles.
Academic Article Expanding role of the medical oncologist in the management of head and neck cancer.
Academic Article Chemoradiotherapy for locally advanced head and neck cancer.
Academic Article Docetaxel and exisulind in previously treated non-small cell lung cancer (NSCLC) patients: a multicenter, phase II clinical trial.
Academic Article Somatic acquisition and signaling of TGFBR1*6A in cancer.
Academic Article Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Academic Article Anti-EGFR therapies: clinical experience in colorectal, lung, and head and neck cancers.
Academic Article Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium.
Academic Article Current treatments and promising investigations in a multidisciplinary setting.
Academic Article A phase II trial of O6-benzylguanine and carmustine in patients with advanced soft tissue sarcoma.
Academic Article Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
Academic Article Multicenter phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck.
Academic Article Introduction: head and neck cancer.
Academic Article Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B.
Academic Article Phase II trial of paclitaxel-topotecan-etoposide followed by consolidation chemoradiotherapy for limited-stage small cell lung cancer: CALGB 30002.
Academic Article Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer.
Academic Article Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancer.
Academic Article Cooperative group research endeavors in small-cell lung cancer: current and future directions.
Academic Article Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904.
Academic Article Phase II trial of weekly dose-dense paclitaxel in extensive-stage small cell lung cancer: cancer and leukemia group B study 39901.
Academic Article Combining radiotherapy with systemic therapies.
Academic Article Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105.
Academic Article Non-small-cell lung cancer: then and now.
Academic Article Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: cancer and leukemia group B (CALEB) 30106, a CALGB-stratified phase II trial.
Academic Article Induction chemotherapy: to use or not to use? That is the question.
Academic Article Serum vascular endothelial growth factor and COX-2/5-LOX inhibition in advanced non-small cell lung cancer: Cancer and Leukemia Group B 150304.
Academic Article Recommended guidelines for the treatment of cancer treatment-induced diarrhea.
Academic Article Randomized phase II trial of erlotinib alone or with carboplatin and paclitaxel in patients who were never or light former smokers with advanced lung adenocarcinoma: CALGB 30406 trial.
Academic Article Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732.
Academic Article Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study.
Academic Article Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck.
Academic Article Optimal therapy for unresectable stage III non-small-cell lung cancer.
Academic Article Similar outcomes between African American and non-African American patients with extensive-stage small-cell lung carcinoma: report from the Cancer and Leukemia Group B.
Academic Article The EphB4 receptor tyrosine kinase promotes lung cancer growth: a potential novel therapeutic target.
Academic Article Induction chemotherapy for head and neck cancer: recent data.
Academic Article A phase II study of halichondrin B analog eribulin mesylate (E7389) in patients with advanced non-small cell lung cancer previously treated with a taxane: a California cancer consortium trial.
Academic Article Cyclooxygenase-2 (COX-2) as a predictive marker for the use of COX-2 inhibitors in advanced non-small-cell lung cancer.
Academic Article Efficacy and safety of axitinib in patients with advanced non-small-cell lung cancer: results from a phase II study.
Academic Article Outcomes of induction chemotherapy followed by concurrent chemoradiation for nasopharyngeal carcinoma.
Academic Article A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation.
Academic Article Randomized phase II trial of docetaxel plus cetuximab or docetaxel plus bortezomib in patients with advanced non-small-cell lung cancer and a performance status of 2: CALGB 30402.
Academic Article Differences in clinical trial patient attributes and outcomes according to enrollment setting.
Academic Article A phase II study of dasatinib in patients with chemosensitive relapsed small cell lung cancer (Cancer and Leukemia Group B 30602).
Academic Article Evidence-based role of bevacizumab in non-small cell lung cancer.
Academic Article Oral cavity tumors in younger patients show a poor prognosis and do not contain viral RNA.
Academic Article Randomized phase II study of pemetrexed, carboplatin, and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small-cell lung cancer: Cancer and Leukemia Group B trial 30407.
Academic Article Cisplatin, irinotecan, and bevacizumab for untreated extensive-stage small-cell lung cancer: CALGB 30306, a phase II study.
Academic Article New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer.
Academic Article Seeking improved outcome in the curative treatment of non-small-cell lung cancer.
Academic Article Angiogenesis inhibition in the treatment of lung cancer.
Academic Article EGFR-directed treatments in SCCHN.
Academic Article Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands.
Academic Article The 2007 Inaugural ASTRO/ASCO/AHNS Multidisciplinary Head and Neck Cancer Symposium.
Academic Article Locally advanced non-small cell lung cancer: the past, present, and future.
Academic Article Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303).
Academic Article A phase II study of carboplatin, etoposide, and exisulind in patients with extensive small cell lung cancer: CALGB 30104.
Academic Article Phase II study of Cediranib (AZD 2171), an inhibitor of the vascular endothelial growth factor receptor, for second-line therapy of small cell lung cancer (National Cancer Institute #7097).
Academic Article Phase II study of the histone deacetylase inhibitor Romidepsin in relapsed small cell lung cancer (Cancer and Leukemia Group B 30304).
Academic Article Pulmonary toxicity in Stage III non-small cell lung cancer patients treated with high-dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: a secondary analysis of Cancer and Leukemia Group B (CALGB) trial 30105.
Academic Article A phase II trial of high dose carboplatin and paclitaxel with G-CSF and peripheral blood stem cell support followed by surgery and/or chest radiation in patients with stage III non-small cell lung cancer: CALGB 9531.
Academic Article CYFRA 21-1 as a prognostic and predictive marker in advanced non-small-cell lung cancer in a prospective trial: CALGB 150304.
Academic Article Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited-stage small-cell lung cancer, CALGB 30206.
Academic Article Competing roads to larynx preservation.
Academic Article Paxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics: relevance to lung cancer.
Academic Article Induction chemotherapy followed by concomitant chemoradiotherapy for non-small cell lung cancer.
Academic Article An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia.
Academic Article Cetuximab in cancers of the lung and head & neck.
Academic Article Interruptions of once-daily thoracic radiotherapy do not correlate with outcomes in limited stage small cell lung cancer: analysis of CALGB phase III trial 9235.
Academic Article Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study.
Academic Article Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected].
Academic Article Prognostic significance of mucin and p53 expression in stage IB non-small cell lung cancer: a laboratory companion study to CALGB 9633.
Academic Article Effects of vascular endothelial growth factor signaling inhibition on human erythropoiesis.
Academic Article Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas.
Academic Article Rare occurrence of EGFRvIII deletion in head and neck squamous cell carcinoma.
Academic Article Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancer.
Academic Article Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy.
Academic Article DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer.
Academic Article Comparison of outcomes of locoregionally advanced oropharyngeal and non-oropharyngeal squamous cell carcinoma over two decades.
Academic Article Combined MET inhibition and topoisomerase I inhibition block cell growth of small cell lung cancer.
Academic Article O-6-methylguanine-deoxyribonucleic acid methyltransferase methylation enhances response to temozolomide treatment in esophageal cancer.
Academic Article Dramatic antitumor effects of the dual MET/RON small-molecule inhibitor LY2801653 in non-small cell lung cancer.
Academic Article Race and competing mortality in advanced head and neck cancer.
Academic Article Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer.
Academic Article Poly (ADP-ribose) polymerase inhibitor efficacy in head and neck cancer.
Academic Article CALGB 30704 (Alliance): A randomized phase II study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small-cell lung cancer.
Academic Article Evaluation of a novel rash scale and a serum proteomic predictor in a randomized phase II trial of sequential or concurrent cetuximab and pemetrexed in previously treated non-small cell lung cancer.
Academic Article A pooled analysis of limited-stage small-cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904.
Academic Article A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor-risk stage III non-small-cell lung cancer: results of CALGB 30605 (Alliance)/RTOG 0972 (NRG).
Academic Article EGFR-based bioradiotherapy in SCCHN.
Academic Article Reply to s. Chakraborty et al.
Academic Article Ex vivo antibody-dependent cellular cytotoxicity inducibility predicts efficacy of cetuximab.
Academic Article Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance).
Academic Article Multitrial Evaluation of Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Extensive-Stage Small-Cell Lung Cancer.
Academic Article Integrated genomic analysis suggests MLL3 is a novel candidate susceptibility gene for familial nasopharyngeal carcinoma.
Academic Article Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.
Academic Article Lung cancer-a fractal viewpoint.
Academic Article ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer.
Academic Article Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE).
Academic Article PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung Cancer.
Academic Article Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation.
Academic Article Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer.
Academic Article The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC.
Academic Article Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012.
Academic Article Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe.
Academic Article Docetaxel (Taxotere) in combination with radiation therapy and the potential of weekly administration in elderly and/or poor performance status patients with advanced non-small cell lung cancer.
Academic Article Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study-CALGB 30607 (Alliance).
Academic Article Validation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials.
Academic Article P2.36: Nivolumab (nivo) in Patients (pts) With Advanced (adv) NSCLC and Central Nervous System (CNS) Metastases (mets): Track: Immunotherapy.
Academic Article Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinoma.
Academic Article PS01.05: Early and Persistent Oligoclonal T Cell Expansion Correlates with Durable Response to Anti-PD1 Therapy in NSCLC: Topic: Medical Oncology.
Academic Article Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies.
Academic Article Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non-Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance).
Academic Article Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
Academic Article Role of dental hardware in oral cavity squamous cell carcinoma in the low-risk nonsmoker nondrinker population.
Academic Article Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor.
Academic Article Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL.
Academic Article Toxicity Related to Radiotherapy Dose and Targeting Strategy: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Locally Advanced Non-Small Cell Lung Cancer.
Academic Article Phase 1 Study of Accelerated Hypofractionated Radiation Therapy With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer: CALGB 31102 (Alliance).
Academic Article Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057).
Academic Article Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy.
Academic Article Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience.
Academic Article The Impact of Staging by Positron-Emission Tomography on Overall Survival and Progression-Free Survival in Patients With Locally Advanced NSCLC.
Academic Article A pooled analysis of individual patient data from National Clinical Trials Network clinical trials of concurrent chemoradiotherapy for limited-stage small cell lung cancer in elderly patients versus younger patients.
Academic Article Exosomal miRNAs species in the blood of small cell and non-small cell lung cancer patients.
Academic Article ALK and ROS1 rearrangement in NSCLC: rapidly evolving standards.
Academic Article Heuristic value-based framework for lung cancer decision-making.
Academic Article CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer.
Academic Article Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression.
Academic Article Similarity and difference in tumor-infiltrating lymphocytes in original tumor tissues and those of in vitro expanded populations in head and neck cancer.
Academic Article Exploring Radiotherapy Targeting Strategy and Dose: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Stage III NSCLC.
Academic Article Management of Early Head and Neck Cancer in Elderly Patients.
Academic Article Clinical prognostic model for older patients with advanced non-small cell lung cancer.
Academic Article Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma.
Academic Article Healthcare resource utilization and associated cost analysis of the PROCLAIM study in patients with stage III non-small-cell lung cancer.
Academic Article Nivolumab treatment beyond RECIST-defined progression in recurrent or metastatic squamous cell carcinoma of the head and neck in CheckMate 141: A subgroup analysis of a randomized phase 3 clinical trial.
Academic Article Palbociclib: a new partner for cetuximab?
Academic Article Effect of Erlotinib Plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients With Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.
Academic Article Epidermal Growth Factor Receptor Blockade in Head and Neck Cancer: What Remains?
Academic Article A pilot study of the pan-class I PI3K inhibitor buparlisib in combination with cetuximab in patients with recurrent or metastatic head and neck cancer.
Academic Article Prolonging Life, but at What Price?
Academic Article A randomized phase 2 network trial of tivantinib plus cetuximab versus cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma.
Academic Article Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases.
Academic Article ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016.
Academic Article Dose and Volume De-Escalation for Human Papillomavirus-Positive Oropharyngeal Cancer is Associated with Favorable Posttreatment Functional Outcomes.
Academic Article Programmed Death-Ligand 1 Immunohistochemistry Assay Comparison Studies in NSCLC: Characterization of the 73-10 Assay.
Academic Article Randomized Study of Maintenance Pemetrexed Versus Observation for Treatment of Malignant Pleural Mesothelioma: CALGB 30901.
Academic Article Optimizing Treatment De-Escalation in Head and Neck Cancer: Current and Future Perspectives.
Academic Article Biomarker-driven therapies for previously treated squamous non-small-cell lung cancer (Lung-MAP SWOG S1400): a biomarker-driven master protocol.
Academic Article Implementation of pharmacogenomic testing in oncology care (PhOCus): study protocol of a pragmatic, randomized clinical trial.
Academic Article Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer.
Academic Article A phase I trial adding poly(ADP-ribose) polymerase inhibitor veliparib to induction carboplatin-paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101.
Academic Article Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis.
Academic Article Is This the Dawn of Precision Oncology in Head and Neck Cancer?
Academic Article Short Communication: Interim toxicity analysis for patients with limited stage small cell lung cancer (LSCLC) treated on CALGB 30610 (Alliance) / RTOG 0538.
Academic Article Beyond PACIFIC: Uncharted Waters.
Academic Article Evaluation of Oncology Trial Results Reporting Over a 10-Year Period.
Academic Article Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors.
Academic Article Veliparib in combination with carboplatin/paclitaxel-based chemoradiotherapy in patients with stage III non-small cell lung cancer.
Academic Article Phase I Study of 2- or 3-Week Dosing of Telisotuzumab Vedotin, an Antibody-Drug Conjugate Targeting c-Met, Monotherapy in Patients with Advanced Non-Small Cell Lung Carcinoma.
Academic Article Veliparib in Combination With Platinum-Based Chemotherapy for First-Line Treatment of Advanced Squamous Cell Lung Cancer: A Randomized, Multicenter Phase III Study.
Academic Article A Phase 1 Trial of Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients With Stage IV NSCLC Study.
Academic Article Risk and response adapted de-intensified treatment for HPV-associated oropharyngeal cancer: Optima paradigm expanded experience.
Academic Article All-trans retinoic acid overcomes solid tumor radioresistance by inducing inflammatory macrophages.
Academic Article Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment.
Academic Article Development and Validation of a Decision Analytical Model for Posttreatment Surveillance for Patients With Oropharyngeal Carcinoma.
Academic Article Long-term Outcomes with Nivolumab as First-line Treatment in Recurrent or Metastatic Head and Neck Cancer: Subgroup Analysis of CheckMate 141.
Academic Article 2022 Presidential Address: Advancing Equitable Cancer Care Through Innovation.
Academic Article Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer.
Academic Article Uncertainty-informed deep learning models enable high-confidence predictions for digital histopathology.
Academic Article High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538.
Academic Article STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer.
Academic Article Plain language summary of the CheckMate 816 study results: nivolumab plus chemotherapy given before surgery for non-small-cell lung cancer.
Concept Pemetrexed
Concept Celecoxib
Concept Poly(ADP-ribose) Polymerase Inhibitors
Concept Bevacizumab
Concept Imatinib Mesylate
Concept Cetuximab
Concept Dasatinib
Concept Filgrastim
Concept Bortezomib
Concept Erlotinib Hydrochloride
Concept Patient Reported Outcome Measures
Concept PAX8 Transcription Factor
Concept Circulating Tumor DNA
Concept Ipilimumab
Concept Matrix Metalloproteinase Inhibitors
Concept Protein Kinase C beta
Concept ErbB Receptors
Academic Article A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer.
Academic Article Early-Stage Lung Cancer: Using Circulating Tumor DNA to Get Personal.
Academic Article Using a Clinically Interpretable End Point Composed of Multiple Outcomes to Evaluate Totality of Treatment Effect in Comparative Oncology Studies.
Academic Article What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?
Academic Article Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1-High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial.
Academic Article Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study.
Academic Article Epstein-Barr Virus DNA Screening in Asymptomatic People without Known Nasopharyngeal Cancer.
Academic Article Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC.
Search Criteria
  • O
  • 6
  • Methylguanine
  • DNA
  • Methyltransferase